亨廷顿蛋白相互作用蛋白1(HIP1)通过改变PDGFR和Rac1信号调控关节炎严重程度及滑膜成纤维细胞侵袭性
研究利用独特同类系大鼠品系的无偏表型驱动策略,在降植烷诱导关节炎中鉴定出HIP1的功能性变异;HIP1为关节炎大鼠及RA患者滑膜成纤维细胞侵袭性所必需,敲低HIP1降低受体酪氨酸激酶介导的反应(包括RAC1活化),HIP1敲除小鼠在KRN血清诱导关节炎中受到保护、病情较轻。结论认为HIP1是新的关节炎严重程度基因,可能是RA的预后生物标志物和治疗靶点。
要点
- 在降植烷诱导关节炎大鼠中鉴定出HIP1的氨基酸改变功能性变异。
- HIP1为关节炎大鼠及RA患者FLS侵袭性所必需。
- HIP1敲除小鼠在KRN血清诱导关节炎中受到保护、病情较轻。
核心结论
- HIP1是新的关节炎严重程度基因,可能是RA的新型预后生物标志物和治疗靶点。
研究设计与样本
- 采用无偏且表型驱动的策略,包括研究独特同类系大鼠品系,以鉴定新的关节炎严重程度和关节损伤基因。
- 研究来自大鼠和RA患者的表达或不表达HIP1的成纤维样滑膜细胞(FLS)的侵袭性、形态和细胞信号。
- 使用HIP1敲除小鼠进行体内验证研究,采用配对t检验。
主要发现
- DNA测序和在降植烷诱导关节炎中研究的亚同类系品系鉴定出HIP1中一个新的氨基酸改变功能性变异。
- HIP1为来自关节炎大鼠和RA患者的FLS侵袭性增加所必需。
- 敲低HIP1表达降低RA FLS中受体酪氨酸激酶介导的反应,包括RAC1活化,影响肌动蛋白细胞骨架和细胞形态,并干扰板状伪足形成,与侵袭性降低一致。
- HIP1敲除小鼠在KRN血清诱导关节炎中受到保护,并发生较轻的疾病。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: While new treatments for rheumatoid arthritis (RA) have markedly improved disease control by targeting immune/inflammatory pathways, current treatments rarely induce remission, underscoring the need for therapies that target other aspects of the disease. Little is known about the regulation of disease severity and joint damage, which are major predictors of disease outcome, and might be better or complementary targets for therapy. In this study, we aimed to discover and characterise a new arthritis severity gene. METHODS: An unbiased and phenotype-driven strategy including studies of unique congenic rat strains was used to identify new arthritis severity and joint damage genes. Fibroblast-like synoviocytes (FLS) from rats and patients with RA expressing or not Huntingtin-interacting protein 1 (HIP1) were studied for invasiveness, morphology and cell signalling. HIP1 knockout mice were used in in vivo confirmatory studies. Paired t-test was used. RESULTS: DNA sequencing and subcongenic strains studied in pristane-induced arthritis identified a new amino acid changing functional variant in HIP1. HIP1 was required for the increased invasiveness of FLS from arthritic rats and from patients with RA. Knocking down HIP1 expression reduced receptor tyrosine kinase-mediated responses in RA FLS, including RAC1 activation, affecting actin cytoskeleton and cell morphology and interfering with the formation of lamellipodia, consistent with reduced invasiveness. HIP1 knockout mice were protected in KRN serum-induced arthritis and developed milder disease. CONCLUSION: HIP1 is a new arthritis severity gene and a potential novel prognostic biomarker and target for therapy in RA.
引用
- Laragione T, Brenner M, Lahiri A, et al. Huntingtin-interacting protein 1 (HIP1) regulates arthritis severity and synovial fibroblast invasiveness by altering PDGFR and Rac1 signalling. Ann Rheum Dis. 2018. PMID: 30049830. doi:10.1136/annrheumdis-2018-213498
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。